Kureha (TSE:4023) raised its earnings guidance for the six months to 30 September 2026, citing earlier crop protection shipments, stronger profitability in its Specialty Chemicals segment, and higher income from investments accounted for using the equity method.
See our latest analysis for Kureha.
Kureha's latest guidance revision comes as the stock trades at ¥4,570, with a 90 day share price return of 23.18% and a 1 year total shareholder return of 35.47%, suggesting momentum has built over recent months.
If this earnings upgrade has you rethinking your sector exposure, it could be a good moment to widen your search with our 28 best rare earth metal stocks
Kureha has enjoyed a strong run after the guidance upgrade, which leaves an obvious question for fresh money: Does the current price still offer an appealing risk reward, or has most of the upside already been reflected?
Preferred Price to Sales Ratio for Kureha: Is it justified?
Kureha is trading at ¥4,570 and is flagged as expensive on a price to sales basis compared with both its industry and an internally assessed fair ratio.
The price to sales, or P/S, ratio compares a company's market value with its revenue. For a business like Kureha that is currently unprofitable, P/S can be a useful cross check because it focuses on sales rather than earnings.
For Kureha, the current P/S ratio is 1x. That sits above the JP Chemicals industry average of 0.8x, which suggests the stock is priced at a richer level than many sector peers based on revenue alone. The fair P/S ratio estimate from the SWS model is also 0.8x, so the current market pricing is higher than both the peer group and the level the model views as more reasonable. This creates a gap that investors may watch if sentiment or expectations change.
Explore the SWS fair ratio for Kureha
Result: Price-to-sales of 1x (OVERVALUED)
However, Kureha still faces risks if current net losses persist or if sector sentiment cools, which could sharpen investor focus on that richer P/S gap.
Find out about the key risks to this Kureha narrative.
Another view on Kureha's valuation
The SWS DCF model points to a different picture for Kureha. At a share price of ¥4,570, the stock is trading above an estimated future cash flow value of ¥2,609.31. That implies the shares look expensive when viewed through this cash flow lens.
This kind of gap can matter. If the market moves closer to the DCF estimate, recent momentum may not be enough to support the current price. The key question is whether you believe Kureha can deliver beyond what the cash flow model currently builds in.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kureha for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 26 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
This mix of positives and concerns around Kureha will mean different things to different investors, so it makes sense to review the full picture and decide quickly how it fits your own approach. To weigh both sides of the story, take a closer look at the 1 key reward and 2 important warning signs.
Looking for more investment ideas beyond Kureha?
If Kureha has sharpened your appetite for new opportunities, now is the time to scan wider, compare options and avoid leaving potential ideas on the table.
- Target potential mispricing by checking stocks that screen as 26 high quality undervalued stocks and see which businesses the market may be overlooking.
- Build resilience into your portfolio by reviewing companies in the 60 resilient stocks with low risk scores that score well on stability and downside protection.
- Hunt for future leaders using the screener containing 68 high quality undiscovered gems before they appear on everyone else's radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com